Novo Nordisk A/S ADR buy The Goldman Sachs Group, Inc.
Start price
28.11.25
/
50%
€42.70
Target price
28.11.26
€46.61
Performance (%)
24.12%
Price
22.01.26
€53.00
Summary
This prediction is currently active. The prediction currently has a performance of 24.12%. This prediction currently runs until 28.11.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novo Nordisk A/S ADR | 7.614% | 7.614% |
| iShares Core DAX® | -1.673% | 2.237% |
| iShares Nasdaq 100 | -1.346% | 0.290% |
| iShares Nikkei 225® | -1.529% | 5.863% |
| iShares S&P 500 | -1.702% | 0.697% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE:NVO) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $60.00 to $54.00. They now have a "buy" rating on the stock.
Ratings data for NVO provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€123.00
30.05.24
30.05.24
€144.02
30.05.25
30.05.25
-49.11%
31.05.25
31.05.25
